Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA).

Drieux F, Ruminy P, Abdel-Sater A, Lemonnier F, Viailly PJ, Fataccioli V, Machand V, Bisig B, Letourneau A, Parrens M, Bossard C, Bruneau J, Dobay P, Veresezan L, Dupuy A, Pujals A, Robe C, Sako N, Copie-Bergman C, Delfau-Larue MH, Picquenot JM, Tilly H, Delarue R, Jardin F, de Leval L, Gaulard P; TENOMIC.

Haematologica. 2019 Sep 5. pii: haematol.2019.226647. doi: 10.3324/haematol.2019.226647. [Epub ahead of print]

2.

In situ BCL2 expression is an independent prognostic factor in HIV-associated DLBCL, a LYMPHOVIR cohort study.

Philippe L, Lancar R, Laurent C, Algarte-Genin M, Chassagne-Clément C, Fabiani B, Pierre Chenard M, Lazure T, Parrens M, Charlotte F, Delattre C, Gibault L, Capron F, Goubin-Versini I, Petitjean B, Boué F, Mounier N, Costello R, Costagliola D, Prevot S, Besson C; ANRS-CO16 LYMPHOVIR Cohort.

Br J Haematol. 2019 Aug 29. doi: 10.1111/bjh.16176. [Epub ahead of print]

PMID:
31468517
3.

Complete remission of immune thrombocytopenia in a 30-year old woman after excision of a right atrial myxoma.

Durand P, Furudoi A, Parrens M, Lazaro E, Viallard JF, Rivière E.

Br J Haematol. 2019 Oct;187(1):e18-e19. doi: 10.1111/bjh.16135. Epub 2019 Aug 6. No abstract available.

PMID:
31388989
4.

Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma.

Crickx E, Poullot E, Moulis G, Goulabchand R, Fieschi C, Galicier L, Meignin V, Coppo P, Delarue R, Casasnovas O, Roos-Weil D, de Leval L, Parrens M, Michel M, Dupuis J, Le Bras F, Fataccioli V, Martin-Garcia N, Godeau B, Haïoun C, Gaulard P, Mahévas M.

Eur J Haematol. 2019 Jul;103(1):35-42. doi: 10.1111/ejh.13239. Epub 2019 May 30.

PMID:
30985955
5.

Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia.

Vial G, Rivière E, Raymond AA, James C, Di-Tommaso S, Dugot-Senant N, Dupuy JW, Yacoub M, Parrens M, Saltel F, Viallard JF.

Front Immunol. 2019 Mar 22;10:523. doi: 10.3389/fimmu.2019.00523. eCollection 2019.

6.

Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells.

Vincent-Fabert C, Soubeyran I, Velasco V, Parrens M, Jeannet R, Lereclus E, Gachard N, Feuillard J, Faumont N.

Cell Mol Immunol. 2019 Jun;16(6):621-624. doi: 10.1038/s41423-019-0228-y. Epub 2019 Apr 9. No abstract available.

PMID:
30967638
7.

Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.

Kilani B, Gourdou-Latyszenok V, Guy A, Bats ML, Peghaire C, Parrens M, Renault MA, Duplàa C, Villeval JL, Rautou PE, Couffinhal T, James C.

J Thromb Haemost. 2019 May;17(5):827-840. doi: 10.1111/jth.14417. Epub 2019 Mar 24.

PMID:
30801958
8.

Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases.

Menguy S, Beylot-Barry M, Parrens M, Ledard AP, Frison E, Comoz F, Battistella M, Szablewski V, Balme B, Croue A, Franck F, Ortonne N, Tournier E, Lamant L, Carlotti A, De Muret A, Le Gall F, Lorton MH, Merlio JP, Vergier B.

Histopathology. 2019 Jun;74(7):1067-1080. doi: 10.1111/his.13832. Epub 2019 Apr 25.

PMID:
30715765
9.

Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas.

Dilly-Feldis M, Aladjidi N, Refait JK, Parrens M, Ducassou S, Rullier A.

Pediatr Blood Cancer. 2019 May;66(5):e27571. doi: 10.1002/pbc.27571. Epub 2019 Jan 13.

PMID:
30637917
10.

[Indolent T-lymphoblastic proliferation in association with localized Castleman disease: A case report].

Chauveau B, Le Loarer F, Bacci J, Baylac F, Dubus P, Ling C, Parrens M.

Ann Pathol. 2019 Feb;39(1):29-35. doi: 10.1016/j.annpat.2018.09.003. Epub 2018 Dec 13. French.

PMID:
30554835
11.

Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA.

Sarkozy C, Copie-Bergman C, Damotte D, Ben-Neriah S, Burroni B, Cornillon J, Lemal R, Golfier C, Fabiani B, Chassagne-Clément C, Parrens M, Herbaux C, Xerri L, Bossard C, Laurent C, Cheminant M, Cartron G, Cabecadas J, Molina T, Salles G, Steidl C, Ghesquières H, Mottok A, Traverse-Glehen A.

Am J Surg Pathol. 2019 Mar;43(3):341-351. doi: 10.1097/PAS.0000000000001198.

PMID:
30540571
12.

Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.

Evrard SM, Péricart S, Grand D, Amara N, Escudié F, Gilhodes J, Bories P, Traverse-Glehen A, Dubois R, Brousset P, Parrens M, Laurent C.

Haematologica. 2019 Apr;104(4):e154-e157. doi: 10.3324/haematol.2018.198572. Epub 2018 Oct 11. No abstract available.

13.

Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications.

Turpin D, Furudoi A, Parrens M, Blanco P, Viallard JF, Duluc D.

Clin Immunol. 2018 Dec;197:130-138. doi: 10.1016/j.clim.2018.09.006. Epub 2018 Sep 13.

PMID:
30219667
14.

Adult Primary Immune Thrombocytopenia: Spleen Histology Findings and Outcomes According to Rituximab Use Based on Analysis of 41 Cases.

Furudoï A, Rivière É, Lazaro E, Furudoï E, Viallard JF, Parrens M.

Am J Surg Pathol. 2018 Mar;42(3):401-412. doi: 10.1097/PAS.0000000000000994.

PMID:
29200102
15.

Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas.

Leclaire Alirkilicarslan A, Dupuy A, Pujals A, Parrens M, Vergier B, Robson A, Delfau-Larue MH, Ingen-Housz-Oro S, Chosidow O, Haioun C, Beylot-Barry M, Merlio JP, Copie-Bergman C, Gaulard P, Ortonne N.

Am J Surg Pathol. 2017 Dec;41(12):1581-1592. doi: 10.1097/PAS.0000000000000956.

PMID:
28945625
16.

Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type.

Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Laforet MP, Beylot-Barry M, Vergier B, Parrens M, Feuillard J, Merlio JP, Gachard N.

J Dermatol Sci. 2017 Nov;88(2):238-246. doi: 10.1016/j.jdermsci.2017.07.008. Epub 2017 Jul 26.

PMID:
28838616
17.

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network.

Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadié M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, Rousselet MC, Brière J, Charlotte F, Chassagne-Clement C, Rousset T, Xerri L, Moreau A, Martin A, Damotte D, Dartigues P, Soubeyran I, Peoch M, Dechelotte P, Michiels JF, de Mascarel A, Berger F, Bossard C, Arbion F, Quintin-Roué I, Picquenot JM, Patey M, Fabre B, Sevestre H, Le Naoures C, Chenard-Neu MP, Bastien C, Thiebault S, Martin L, Delage M, Filleron T, Salles G, Molina TJ, Delsol G, Brousset P, Gaulard P.

J Clin Oncol. 2017 Jun 20;35(18):2008-2017. doi: 10.1200/JCO.2016.71.2083. Epub 2017 May 1.

PMID:
28459613
18.

BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial.

Petrella T, Copie-Bergman C, Brière J, Delarue R, Jardin F, Ruminy P, Thieblemont C, Figeac M, Canioni D, Feugier P, Fabiani B, Leroy K, Parrens M, André M, Haioun C, Salles GA, Gaulard P, Tilly H, Jais JP, Molina TJ.

Ann Oncol. 2017 May 1;28(5):1042-1049. doi: 10.1093/annonc/mdx022.

PMID:
28327893
19.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS.

Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.

20.

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.

Dobay MP, Lemonnier F, Missiaglia E, Bastard C, Vallois D, Jais JP, Scourzic L, Dupuy A, Fataccioli V, Pujals A, Parrens M, Le Bras F, Rousset T, Picquenot JM, Martin N, Haioun C, Delarue R, Bernard OA, Delorenzi M, de Leval L, Gaulard P.

Haematologica. 2017 Apr;102(4):e148-e151. doi: 10.3324/haematol.2016.158428. Epub 2017 Jan 12. No abstract available.

21.

Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients.

Rossille D, Azzaoui I, Feldman AL, Maurer MJ, Labouré G, Parrens M, Pangault C, Habermann TM, Ansell SM, Link BK, Tarte K, Witzig TE, Lamy T, Slager SL, Roussel M, Milpied N, Cerhan JR, Fest T.

Leukemia. 2017 Apr;31(4):988-991. doi: 10.1038/leu.2016.385. Epub 2017 Jan 27. No abstract available.

22.

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Sarkozy C, Molina T, Ghesquières H, Michallet AS, Dupuis J, Damotte D, Morsschauser F, Parrens M, Martin L, Dartigues P, Stamatoullas A, Hirsch P, Fabiani B, Bouabdallah K, da Silva MG, Maerevoet M, Laurent C, Coiffier B, Salles G, Traverse-Glehen A.

Haematologica. 2017 Jan;102(1):150-159. doi: 10.3324/haematol.2016.152256. Epub 2016 Oct 6.

23.

Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.

Roberti A, Dobay MP, Bisig B, Vallois D, Boéchat C, Lanitis E, Bouchindhomme B, Parrens MC, Bossard C, Quintanilla-Martinez L, Missiaglia E, Gaulard P, de Leval L.

Nat Commun. 2016 Sep 7;7:12602. doi: 10.1038/ncomms12602.

24.

Lung intragraft donor-specific antibodies as a risk factor for graft loss.

Visentin J, Chartier A, Massara L, Linares G, Guidicelli G, Blanchard E, Parrens M, Begueret H, Dromer C, Taupin JL.

J Heart Lung Transplant. 2016 Dec;35(12):1418-1426. doi: 10.1016/j.healun.2016.06.010. Epub 2016 Jun 24.

PMID:
27450460
25.

Spleen Histologic Appearance in Common Variable Immunodeficiency: Analysis of 17 Cases.

Furudoï A, Gros A, Stanislas S, Hamidou M, Furudoï E, Oksenhendler É, Merlio JP, Viallard JF, Parrens M.

Am J Surg Pathol. 2016 Jul;40(7):958-67. doi: 10.1097/PAS.0000000000000661.

PMID:
27158760
26.

Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients.

Lamarque M, Bossard C, Contejean A, Brice P, Parrens M, Le Gouill S, Brière J, Bouabdallah R, Canioni D, Tilly H, Bouchindhomme B, Bachy E, Delarue R, Haioun C, Gaulard P.

Haematologica. 2016 Mar;101(3):e103-6. doi: 10.3324/haematol.2015.135400. Epub 2015 Dec 24. No abstract available.

27.

Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.

Thomas de Montpréville V, Quilhot P, Chalabreysse L, De Muret A, Hofman V, Lantuéjoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Besse B, Marx A, Molina TJ.

Pathol Res Pract. 2015 Dec;211(12):996-1002. doi: 10.1016/j.prp.2015.10.005. Epub 2015 Oct 19.

PMID:
26534878
28.

[A rare splenic lesion].

Zehani A, Chelly I, Ben Rejeb H, Parrens M, de Mascarel A, Kchir N.

Ann Pathol. 2015 Dec;35(6):520-2. doi: 10.1016/j.annpat.2015.05.007. Epub 2015 Sep 14. French. No abstract available.

PMID:
26383550
29.

MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.

Copie-Bergman C, Cuillière-Dartigues P, Baia M, Briere J, Delarue R, Canioni D, Salles G, Parrens M, Belhadj K, Fabiani B, Recher C, Petrella T, Ketterer N, Peyrade F, Haioun C, Nagel I, Siebert R, Jardin F, Leroy K, Jais JP, Tilly H, Molina TJ, Gaulard P.

Blood. 2015 Nov 26;126(22):2466-74. doi: 10.1182/blood-2015-05-647602. Epub 2015 Sep 15.

PMID:
26373676
30.

Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, Dartigues P, Fabiani B, Ledoux-Pilon A, Montagne K, Molina T, Patey M, Tas P, Peoch M, Petit B, Petrella T, Picquenot JM, Rousset T, Rousselet MC, Soubeyran I, Thiebault S, Tournilhac O, Xerri L, Gisselbrecht C, Haioun C, Delsol G, Gaulard P.

Haematologica. 2015 Sep;100(9):e361-4. doi: 10.3324/haematol.2015.126300. Epub 2015 Jun 4. No abstract available.

31.

[Pathology of the mediastinum. Case 4. Type B2 thymoma].

Parrens M.

Ann Pathol. 2015 Jun;35(3):230-5. doi: 10.1016/j.annpat.2015.03.001. Epub 2015 May 23. French. No abstract available.

PMID:
26004310
32.

[Pathology of the mediastinum. Case 3. Type AB thymoma].

Parrens M.

Ann Pathol. 2015 Jun;35(3):224-9. doi: 10.1016/j.annpat.2015.03.007. Epub 2015 May 20. French. No abstract available.

PMID:
26001353
33.

Anthracosis mimicking mediastinal lymph node metastases with 18F-FCholine in high-risk prostate cancer.

Pinaquy JB, Fernandez P, Pasticier G, Parrens M, De Clermont H.

Clin Nucl Med. 2015 Apr;40(4):e253-4. doi: 10.1097/RLU.0000000000000707.

PMID:
25674859
34.

Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 cases.

Fauconneau A, Pham-Ledard A, Cappellen D, Frison E, Prochazkova-Carlotti M, Parrens M, Dalle S, Joly P, Viraben R, Franck F, Ingen-Housz-Oro S, Giacchero D, Jullié ML, Vergier B, Merlio JP, Beylot-Barry M.

Br J Dermatol. 2015 Jun;172(6):1547-1554. doi: 10.1111/bjd.13690. Epub 2015 May 16.

PMID:
25645336
35.

[KHSV/EBV associated germinotropic lymphoproliferative disorder: a rare entity, case report and review of the literature].

Taris M, de Mascarel A, Riols M, Delwail V, Milpied N, Dubus P, Parrens M.

Ann Pathol. 2014 Oct;34(5):373-7. doi: 10.1016/j.annpat.2014.06.013. Epub 2014 Sep 26. Review. French.

PMID:
25439990
36.

Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.

Bossard C, Dobay MP, Parrens M, Lamant L, Missiaglia E, Haioun C, Martin A, Fabiani B, Delarue R, Tournilhac O, Delorenzi M, Gaulard P, de Leval L.

Blood. 2014 Nov 6;124(19):2983-6. doi: 10.1182/blood-2014-07-584953. Epub 2014 Sep 15.

PMID:
25224410
38.

[Rythmic-pathology: the French national pathology network for thymic epithelial tumours].

Chalabreysse L, Thomas De Montpreville V, De Muret A, Hofman V, Lantuejoul S, Parrens M, Payan MJ, Rouquette I, Secq V, Girard N, Marx A, Besse B, Molina TJ.

Ann Pathol. 2014 Feb;34(1):87-91. doi: 10.1016/j.annpat.2014.01.010. Epub 2014 Feb 21. French.

PMID:
24630641
39.

Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.

Neuville A, Collin F, Bruneval P, Parrens M, Thivolet F, Gomez-Brouchet A, Terrier P, de Montpreville VT, Le Gall F, Hostein I, Lagarde P, Chibon F, Coindre JM.

Am J Surg Pathol. 2014 Apr;38(4):461-9. doi: 10.1097/PAS.0000000000000184.

PMID:
24625414
40.

RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells.

Chanut A, Duguet F, Marfak A, David A, Petit B, Parrens M, Durand-Panteix S, Boulin-Deveza M, Gachard N, Youlyouz-Marfak I, Bordessoule D, Feuillard J, Faumont N.

Leukemia. 2014 Apr;28(4):871-9. doi: 10.1038/leu.2013.274. Epub 2013 Sep 23.

PMID:
24056880
41.

Lymphomatoid papulosis type D: an aggressive histology for an indolent disease.

Bertolotti A, Pham-Ledard AL, Vergier B, Parrens M, Bedane C, Beylot-Barry M.

Br J Dermatol. 2013 Nov;169(5):1157-9. doi: 10.1111/bjd.12463. Review. No abstract available.

PMID:
23746266
42.

Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response.

Robles M, Vigouroux S, Tabrizi R, Bouabdallah K, Dilhuydy MS, Parrens M, Leguay T, Pigneux A, Dumas PY, Lascaux A, Duclos C, Marit G, Milpied N.

Bone Marrow Transplant. 2013 Nov;48(11):1484-5. doi: 10.1038/bmt.2013.86. Epub 2013 Jun 3. No abstract available.

PMID:
23727750
43.

Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.

d'Elbée JM, Parrens M, Mercié P, Longy Boursier M, Dieval C, de Mascarel A, Duffau P, Dubus P, Fricain JC.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):e185-90. doi: 10.1016/j.oooo.2013.03.017. Epub 2013 May 10.

PMID:
23669204
44.

Metastatic melanoma with leukaemia-like evolution.

Bertolotti A, Conte H, Amazan E, Dutriaux C, Ezzedine K, Parrens M, Vergier B, Taieb A, Jouary T.

Acta Derm Venereol. 2013 Nov;93(6):729-30. doi: 10.2340/00015555-1581. No abstract available.

45.

[Pitfalls and update in haematopathology. Case 8: angioimmunoblastic T-cell lymphoma].

Parrens M.

Ann Pathol. 2012 Oct;32(5):371-6. doi: 10.1016/j.annpat.2012.07.022. Epub 2012 Oct 10. French. No abstract available.

PMID:
23141947
46.

[ALK+ diffuse large B-cell lymphoma].

Parrens M.

Ann Pathol. 2012 Oct;32(5):351-5. doi: 10.1016/j.annpat.2012.08.001. Epub 2012 Oct 9. French. No abstract available.

PMID:
23141944
47.

Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.

Valleron W, Ysebaert L, Berquet L, Fataccioli V, Quelen C, Martin A, Parrens M, Lamant L, de Leval L, Gisselbrecht C, Gaulard P, Brousset P.

Blood. 2012 Nov 8;120(19):3997-4005. doi: 10.1182/blood-2012-06-438135. Epub 2012 Sep 18.

PMID:
22990019
48.

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.

Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M, Feuillard J.

Leukemia. 2013 Jan;27(1):183-9. doi: 10.1038/leu.2012.257. Epub 2012 Sep 4.

PMID:
22944768
49.

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P.

Blood. 2012 Aug 16;120(7):1466-9. doi: 10.1182/blood-2012-02-408542. Epub 2012 Jul 3.

50.

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Delfau-Larue MH, de Leval L, Joly B, Plonquet A, Challine D, Parrens M, Delmer A, Salles G, Morschhauser F, Delarue R, Brice P, Bouabdallah R, Casasnovas O, Tilly H, Gaulard P, Haioun C.

Haematologica. 2012 Oct;97(10):1594-602. doi: 10.3324/haematol.2011.061507. Epub 2012 Feb 27.

Supplemental Content

Loading ...
Support Center